INJ sees a slight uptick, now at $34.61, hinting at a bullish reversal amidst $254M trading activity. Injective Protocol’s gas-free cross-chain trading fuels popularity, with market cap soaring over $3.2B. AAVE eyes the $100 mark after a 0.44% increase, signaling substantial accumulation and potential breakout. The bearish channel formation of the Injective Protocol (INJ) has The post Will INJ and AAVE Navigate Market Volatility to Emerge as Top Performers? appeared first on Coin Edition .
